Results 221 to 230 of about 3,248 (232)

Could the Drug Tafenoquine Revolutionize Treatment of Babesia microti Infection?

Journal of Infectious Diseases, 2019
Dana G Mordue, Gary P Wormser
exaly  

Tafenoquine

2016
openaire   +1 more source

Tafenoquine for malaria prophylaxis in adults: An integrated safety analysis

Travel Medicine and Infectious Disease, 2017
Anne Novitt-Moreno, Janet Ransom, Stephen Toovey   +2 more
exaly  

Tafenoquine at therapeutic concentrations does not prolong fridericia‐corrected QT interval in healthy subjects

Journal of Clinical Pharmacology, 2014
Justin A Green, Azra Hussaini, NicK Carter   +2 more
exaly  

Occupational asthma from tafenoquine in the pharmaceutical industry: implications for QSAR

Occupational Medicine, 2015
J Cannon, M Seed
exaly  

Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study

Lancet, The, 2014
Alejandro Llanos-Cuentas, Srivicha Krudsood, Sanjay K Kochar   +2 more
exaly  

Blood schizontocidal activity of WR 238605 (Tafenoquine) against Plasmodium cynomolgi and Plasmodium fragile infections in rhesus monkeys

Acta Tropica, 2003
S K Puri, G P Dutta
exaly  

Tafenoquine (Arakoda; Krintafel) for malaria.

The Medical letter on drugs and therapeutics, 2019
openaire   +1 more source

Tafenoquine for Plasmodium vivax malaria infection

2013
Senaka Rajapakse, Chaturaka Rodrigo, Sumadhya D Fernando   +2 more
openaire   +1 more source

Molecule of the month. Tafenoquine succinate.

Drug news & perspectives, 2004
openaire   +1 more source